Provided by Tiger Trade Technology Pte. Ltd.

Cassava Sciences Inc

2.38
0.0000
Volume:- -
Turnover:- -
Market Cap:114.97M
PE:-1.08
High:2.38
Open:2.38
Low:2.38
Close:2.38
52wk High:4.98
52wk Low:1.15
Shares:48.31M
Float Shares:43.48M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1976
EPS(LYR):-1.4620
ROE:-85.44%
ROA:-24.80%
PB:1.41
PE(LYR):-1.63

Loading ...

Company Profile

Company Name:
Cassava Sciences Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.